Publications by authors named "Jason Alter"

Claim this Profile
C
Correction to: ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.
Ronald Tutrone, Ben Lowentritt, Brian Neuman, Michael J Donovan, Elliot Hallmark, Jason Alter

Prostate Cancer Prostatic Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.
Ronald Tutrone, Ben Lowentritt, Brian Neuman, Michael J Donovan, Elliot Hallmark, Jason Alter

Prostate Cancer Prostatic Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating biomarkers and multi-parametric MRI to provide enhanced clinical diagnosis for prostate cancer.
Jason Alter, David M Albala

Front Urol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome.
Alexander Kretschmer, Ronald Tutrone, Jason Alter, Elena Berg, Christian Fischer

World J Urol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy.
Alexander Kretschmer, Holger Kajau, Eric Margolis, Ronald Tutrone, Tobias Grimm, Jason Alter

Sci Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy.
James McKiernan, Mikkel Noerholm, Vasisht Tadigotla, Sonia Kumar, Phillipp Torkler, Jason Alter

BMC Urol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.
Daniel E Spratt, Jingbin Zhang, María Santiago-Jiménez, Robert T Dess, John W Davis, Jason Alter

J Clin Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis